Stratified medicine is changing our concept of disease Understanding the different molecular pathways behind a disease will help doctors to manage it.…
Chemoprevention with tamoxifen cuts risk of breast cancer by almost 30% Tamoxifen used in primary prevention cuts the risk of breast cancer by around 30% and this benefit lasts for at least 20 years, a long-term follow-up of the International Breast Cancer Intervention Study shows.…
Antimicrobial resistance will lead to an additional 10 million deaths each year worldwide by 2050 Failure to address growing resistance to antibiotics and other drugs will result in the deaths of an additional 10 million people each year worldwide by 2050 and cost the global economy up to US$100tn, projects a UK report.…
Pharmacy risks being sidelined as NHS evolves, report warns Pharmacists risk missing the opportunity to expand their clinical responsibilities within a changing NHS in England because of a failure to reform funding arrangements and a lack of consistent messages about the role the profession can play.…
Pregnant women warned not to stop taking prescribed drugs without medical advice Two-thirds of maternal deaths are due to an unrelated medical or mental health condition which has not been well-controlled rather than from a complication of pregnancy, says a new report.…
EMA says flu vaccine is safe after deaths in ItalyThere is no evidence that Novartis’s Fluad is unsafe, the European Medicines Agency (EMA) says, after 13 deaths in Italy were reported as being associated with the influenza vaccine.…
Pharmacy flu vaccinations increase in Wales Nearly 8,000 people were vaccinated against influenza at Welsh pharmacies in 2013–2014, according to data published by the Welsh Government.…
Initial Fluad investigations find no manufacturing defectPreliminary investigations have found no manufacturing defect in the influenza vaccine Fluad, which has been linked to the deaths of 13 older people in Italy.…
Phase I trial of GlaxoSmithKline’s Ebola vaccine shows it is well tolerated No major adverse events were reported in an Ebola vaccine phase I trial involving 20 volunteers.…
Our knowledge and understanding of e-cigarettes is still limitedA letter from M Cunningham exhorts “those in the profession opposed to e-cigarettes to come around in light of growing evidence” ( The Pharmaceutical Journal 2014;293:599). To support this argument, she cites the opinion of experts who spoke at a recent co…